Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
Cervical cancer in ethiopia: Survival of 1,059 patients who received oncologic therapy
Oncologist, Volume 19, No. 7, Year 2014
Notification
URL copied to clipboard!
Description
Background. Almost 500,000 women are newly diagnosed with cervical cancer (CC) every year, the majority from developing countries. There is little information on the survival of these patients. Our primary objective was to evaluate consecutive CC patients presenting over 4 years at the only radiotherapy center in Ethiopia. Methods. All patients with CC from September 2008 to September 2012 who received radiotherapy and/or surgery were included (without brachytherapy). Vital status was obtained through telephone contact or patient cards. Results. Of 2,300 CC patients, 1,059 patients with standardized treatment were included. At the end of the study, 249 patients had died; surviving patients had a median follow-up of 16.5 months; the 10% and 90% percentiles were 3.0 and 32.7 months, respectively. Mean age was 49 years (21-91 years). The majority of patients presented with International Federation of Gynecology and Obstetrics stage IIb-IIIa (46.7%). Because of progression during the waiting time (median 3.8 months), this proportion declined to 19.3% at the beginning of radiotherapy. The 1- and 2-year overall survival probabilities were 90.4% and 73.6%. If assuming a worst-case scenario (i.e., if all patients not available for follow-up after 6 months had died), the 2-year survival probability would be 45.4%. Conclusion. This study gives a thorough 4-year overview of treated patients with CC in Ethiopia. Given the limited treatment availability, a relatively high proportion of patients survived 2 years. More prevention and early detection at all levels of the health care system are needed. Increasing the capacity for external-beam radiation as well as options for brachytherapy would facilitate treatment with curative intention. © AlphaMed Press 2014.
Available Materials
https://efashare.b-cdn.net/share/pmc/articles/PMC4077439/bin/supp_19_7_727__index.html
https://efashare.b-cdn.net/share/pmc/articles/PMC4077439/bin/supp_the2013-0326_Supplemental_FigureS1.pdf
https://efashare.b-cdn.net/share/pmc/articles/PMC4077439/bin/supp_the2013-0326_Supplemental_FigureS2.pdf
Authors & Co-Authors
Kantelhardt, Eva Eva Johanna Ohanna
Germany, Halle
Martin-luther-universität Halle-wittenberg
Moelle, Ulrike
Germany, Halle
Martin-luther-universität Halle-wittenberg
Begoihn, Matthias
Germany, Halle
Martin-luther-universität Halle-wittenberg
Addissie, Adamu
Ethiopia, Addis Ababa
School of Medicine
Trocchi, P.
Ethiopia, Addis Ababa
School of Medicine
Bekuretsion, Yonas
Ethiopia, Addis Ababa
School of Medicine
Hezkiel, Petros
Ethiopia, Addis Ababa
School of Medicine
Stang, Andreas
Germany, Halle
Martin-luther-universität Halle-wittenberg
United States, Boston
Boston University
Thomssen, C.
Germany, Halle
Martin-luther-universität Halle-wittenberg
Vordermark, Dirk
Ethiopia, Addis Ababa
School of Medicine
Gemechu, Tufa W.
Ethiopia, Addis Ababa
School of Medicine
Gebrehiwot, Yirgu
Ethiopia, Addis Ababa
School of Medicine
Tigeneh, Wondemagegnhu
Ethiopia, Addis Ababa
School of Medicine
Aynalem, Abreha
Ethiopia, Addis Ababa
School of Medicine
Assefa, Mathewos Dilbetigle
Ethiopia, Addis Ababa
School of Medicine
Statistics
Citations: 65
Authors: 15
Affiliations: 3
Identifiers
Doi:
10.1634/theoncologist.2013-0326
ISSN:
10837159
e-ISSN:
1549490X
Research Areas
Cancer
Health System And Policy
Study Design
Cohort Study
Study Locations
Ethiopia
Participants Gender
Female